4//SEC Filing
Saxonov Serge 4
Accession 0001610717-26-000003
CIK 0001770787other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:52 PM ET
Size
11.2 KB
Accession
0001610717-26-000003
Insider Transaction Report
Form 4
Saxonov Serge
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2026-01-05$1.20/sh+50,000$60,000→ 1,071,556 total - Exercise/Conversion
Stock Option (right to buy)
2026-01-05−17,463→ 0 totalExercise: $1.20Exp: 2027-10-18→ Class A Common Stock (17,463 underlying) - Exercise/Conversion
Stock Option (right to buy)
2026-01-05−32,537→ 173,600 totalExercise: $1.20Exp: 2027-10-18→ Class A Common Stock (32,537 underlying)
Holdings
- 27(indirect: See footnote)
Class A Common Stock
- 213,250(indirect: See footnote)
Class A Common Stock
- 58,000(indirect: See footnote)
Class A Common Stock
Footnotes (4)
- [F1]The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- [F2]The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- [F3]The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
- [F4]All of the shares subject to the option are fully vested and exercisable as of the date hereof.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
Related Parties
1- filerCIK 0001786720
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:52 PM ET
- Size
- 11.2 KB